Market Research Logo

United States Neurostimulation Devices Market Outlook to 2023

United States Neurostimulation Devices Market Outlook to 2023

Summary

GlobalData’s new report, United States Neurostimulation Devices Market Outlook to 2023, provides key market data on the United States Neurostimulation Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Neurostimulation Devices market segments - Cortical Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Spinal Cord Stimulators, Vagus Nerve Stimulators.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
  • 2016 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Neurostimulation Devices market.
  • Key players covered include Medtronic plc, Boston Scientific Corp, St. Jude Medical LLC and Others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurostimulation Devices Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurostimulation Devices Market, United States
3.1 Neurostimulation Devices Market, United States, Revenue ($m), 2009-2016
3.2 Neurostimulation Devices Market, United States, Revenue ($m), 2016-2023
3.3 Neurostimulation Devices Market, United States, Volume (Units), 2009-2016
3.4 Neurostimulation Devices Market, United States, Volume (Units), 2016-2023
3.5 Neurostimulation Devices Market, United States, Average Price ($), 2009-2023
3.6 Neurostimulation Devices Market, United States, Distribution Share by Revenue ($m), 2015-2016
3.7 Neurostimulation Devices Market, United States, Company Share by Revenue ($m), 2016
4 Overview of Key Companies in United States, Neurostimulation Devices Market
4.1 Medtronic Plc
4.1.1 Company Overview
4.2 Boston Scientific Corp
4.2.1 Company Overview
4.3 St. Jude Medical LLC
4.3.1 Company Overview
4.4 LivaNova PLC
4.4.1 Company Overview
4.5 Integra LifeSciences Holdings Corp
4.5.1 Company Overview
5 Neurostimulation Devices Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million
6.2 Equity Offerings
6.2.1 Helius Medical Technologies Raises USD9.5 Million in Public Offering of Shares
6.2.2 Zynex to Raise USD1.5 Million in Private Placement
6.2.3 Helius Medical Raises USD1.4 Million in Private Placement of Shares upon Exercise of Warrants
6.2.4 NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants
6.3 Venture Financing
6.3.1 Dynatronics Raises USD7.8 Million in Venture Financing
6.3.2 SetPoint Medical Raises Funds through Venture Financing
6.3.3 ReliefBand Technologies to Raise USD8 Million in Venture Financing
6.3.4 Checkpoint Surgical Raises USD0.5 Million in Venture Financing
6.3.5 ElectroCore Raises USD1.5 Million in Venture Financing
6.3.6 Autonomic Technologies Raises Additional USD23 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions’ Board of Directors
7.1.2 Mar 29, 2017: Dynatronics Welcomes Cynthia L. McHenry as Its New Vice President of Operations
7.1.3 Mar 21, 2017: SPR Therapeutics Appoints Michael P. Chuisano to Board of Directors
7.1.4 Mar 01, 2017: DJO Global Announces Appointment of Bryan McMillan as President, Regeneration
7.1.5 Feb 27, 2017: Gary Haire to Join Integer as Executive Vice President and Chief Financial Officer
7.1.6 Feb 21, 2017: SANUWAVE Announces Hiring of Andre Mouton as VP of International Sales and Relations
7.1.7 Feb 03, 2017: Helius Medical Technologies Announces Resignation of Director
7.1.8 Nov 14, 2016: DJO Global Announces Appointment of Brady Shirley as President and Chief Executive Officer
7.1.9 Nov 08, 2016: NeuroMetrix Announces Promotion of Frank McGillin to Chief Commercial Officer
7.1.10 Oct 10, 2016: Professor Ian Meredith To Join Boston Scientific As Executive Vice President And Global Chief Medical Officer
7.1.11 Oct 03, 2016: NuVasive Appoints Joan Stafslien as Executive Vice President, General Counsel
7.1.12 Sep 30, 2016: Dynatronics Welcomes David A. Wirthlin as Its New Chief Financial Officer
7.1.13 Sep 28, 2016: Bioness Welcomes Eric Grigsby (MD, MBA) As Chief Medical Officer
7.1.14 Sep 12, 2016: NuVasive Names Jason M. Hannon President and Chief Operating Officer; Patrick S. Miles Assumes Role of Vice Chairman
7.1.15 Sep 12, 2016: SetPoint Medical Expands Management Team to Support Advancement of Bioelectronic Medicine Platform
7.1.16 Sep 06, 2016: DJO Global Announces Appointment of Mike Eklund as Chief Operating Officer and Chief Financial Officer
7.1.17 Aug 08, 2016: Helius Medical Technologies Appoints Thomas Griffin to Board of Directors and Chairman of the Audit Committee
7.1.18 Aug 01, 2016: Michael D. O'Halleran and Patrick S. Miles Elected to NuVasive Board of Directors
7.1.19 Jul 21, 2016: Reorganization of electroCore management team as Frank Amato becomes CEO and founder JP Errico becomes Chief Science and Strategy Officer
7.1.20 Jul 13, 2016: Boston Scientific Elects Yoshiaki Fujimori to Board of Directors
7.1.21 Jun 15, 2016: Brett Reynolds Rejoins Cogentix Medical As Chief Financial Officer
7.1.22 Jun 06, 2016: Zynex Hires Vice President of Operations
7.1.23 Jun 01, 2016: Zynex Hires Vice President of Finance
7.1.24 Jun 01, 2016: Brainsway announces resignation of Guy Ezekiel, president and CEO
7.1.25 May 26, 2016: Dynatronics Strengthens Its Sales Management Team
7.1.26 May 23, 2016: Dynatronics Announces Transition in Executive Management
7.1.27 May 17, 2016: EndoStim Names Rohan Hoare, Ph.D., as New President and CEO
7.2 Financial Announcements
7.2.1 May 15, 2017: Dynatronics Announces Fiscal 2017 Third Quarter Results
7.2.2 May 15, 2017: Zynex Announces 2017 First Quarter Results
7.2.3 May 10, 2017: DJO Global Announces Financial Results for First Quarter 2017
7.2.4 May 08, 2017: Nevro Reports First Quarter 2017 Financial Results
7.2.5 May 02, 2017: Halyard Health Announces First Quarter 2017 Results
7.2.6 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017
7.2.7 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results
7.2.8 Apr 25, 2017: NuVasive Announces First Quarter 2017 Financial Results
7.2.9 Apr 20, 2017: NeuroMetrix Reports Q1 2017 Financial Results
7.2.10 Apr 20, 2017: Electrical Geodesics: Results for the year ended 31 December 2016
7.2.11 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter
7.2.12 Apr 04, 2017: Sanuwave Health Reports Record Revenue in 2016 and Provides a Business Update
7.2.13 Apr 03, 2017: Zynex Announces 2016 Year End Results
7.2.14 Mar 29, 2017: Brainsway Closes 2016 With 69 Percent Increase in Year-over-Year Revenue Growth
7.2.15 Mar 08, 2017: DJO Global Announces Financial Results for Fourth Quarter and Fiscal Year End 2016
7.2.16 Mar 06, 2017: Electrical Geodesics: Business Update
7.2.17 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results
7.2.18 Feb 27, 2017: Halyard Health Announces Fourth Quarter and Full-Year 2016 Results, Provides 2017 Outlook
7.2.19 Feb 23, 2017: Nevro Reports Fourth Quarter and Full Year 2016 Financial Results and Provides 2017 Outlook
7.2.20 Feb 13, 2017: Dynatronics Announces 16.6% increase in Revenues for Fiscal 2017 Second Quarter
7.2.21 Feb 09, 2017: NuVasive Reports Fourth Quarter And Full Year 2016 Financial Results
7.2.22 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016
7.2.23 Jan 26, 2017: NeuroMetrix Reports Q4 and Full Year 2016 Financial Results
7.2.24 Jan 26, 2017: SANUWAVE Health Achieves High End of Revenue Guidance for Q4 2016
7.2.25 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues
7.2.26 Jan 10, 2017: NeuroMetrix Reports Strong Quell Demand in Q4 2016
7.2.27 Jan 09, 2017: NuVasive Announces Select Preliminary Unaudited Full Year 2016 Financial Results and 2017 Outlook
7.2.28 Nov 14, 2016: Dynatronics Announces 10% increase in Top Line Sales for Fiscal 2017 First Quarter
7.2.29 Nov 10, 2016: Zynex Announces Third Quarter 2016 Profit
7.2.30 Nov 08, 2016: DJO Global Announces Financial Results for Third Quarter
7.2.31 Nov 07, 2016: Nevro Reports Third Quarter 2016 Financial Results
7.2.32 Nov 04, 2016: MRI Interventions Announces 2016 Third Quarter and Nine Month Results
7.2.33 Nov 02, 2016: Halyard Health Announces Third Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
7.2.34 Oct 26, 2016: Boston Scientific Announces Results For Third Quarter 2016
7.2.35 Oct 25, 2016: NuVasive Reports Third Quarter 2016 Financial Results
7.2.36 Oct 20, 2016: NeuroMetrix Reports Q3 2016 Financial Results
7.2.37 Oct 19, 2016: St. Jude Medical Reports Third Quarter 2016 Results
7.2.38 Sep 26, 2016: Dynatronics Announces Fourth Quarter and Fiscal Year 2016 Financial Results
7.2.39 Sep 22, 2016: Mainstay Medical Announces Half Year Financial Results
7.2.40 Aug 29, 2016: Electrical Geodesics Announces Six Month Period of Strong Revenue Growth
7.2.41 Aug 26, 2016: Electrical Geodesics Announces A Period of Strong Revenue Growth
7.2.42 Aug 22, 2016: Zynex Announces Second Quarter 2016 Results
7.2.43 Aug 18, 2016: Brainsway Sustains Consistent Revenue Growth for Third Quarter in a Row
7.2.44 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results
7.2.45 Aug 15, 2016: SANUWAVE Health Reports Second Quarter Financial Results and Provides a Business Update
7.2.46 Aug 08, 2016: Nevro Reports Second Quarter 2016 Financial Results
7.2.47 Aug 03, 2016: Halyard Health Announces Second Quarter 2016 Results, Raises Its Full-Year 2016 Outlook
7.2.48 Jul 28, 2016: Electrical Geodesics Provides Trading Update
7.2.49 Jul 28, 2016: Integer Holdings Reports 2016 Second Quarter Results
7.2.50 Jul 28, 2016: Boston Scientific Announces Results For Second Quarter 2016
7.2.51 Jul 28, 2016: DJO Global Announces Financial Results for Second Quarter 2016
7.2.52 Jul 26, 2016: NuVasive Reports Second Quarter 2016 Financial Results
7.2.53 Jul 21, 2016: NeuroMetrix Reports Q2 2016 Financial Results and Highlights
7.2.54 Jul 20, 2016: St. Jude Medical Reports Second Quarter 2016 Results
7.2.55 Jun 01, 2016: Brainsway Announces Doubled Revenue in First Quarter
7.2.56 May 25, 2016: Zynex Announces First Quarter 2016 Results
7.2.57 May 18, 2016: Wake Forest Baptist Fiscal Year 2016 Third Quarter Financial Performance
7.2.58 May 17, 2016: SANUWAVE Health Reports First Quarter Financial Results and Provides a Business Update
7.2.59 May 16, 2016: Dynatronics Announces Fiscal 2016 Third Quarter Financial Results
7.3 Government and Public Interest
7.3.1 Jun 13, 2016: Sanofi Files Definitive Consent Solicitation To Remove And Replace Medivation’s Board
7.3.2 Jun 01, 2016: Sanofi Requests Record Date for Consent Solicitation to Remove and Replace Medivation’s Board of Directors
7.4 Legal And Regulatory
7.4.1 Feb 03, 2017: Easton Pharmaceuticals and BMV Medica Announces First Shipment of Gynofit To Multi-National Pharmaceutical Company, Gedeon Richter, Towards Its Purchase Order, Has Been Received For February 16th Product Launch in Puerto Vallarta, Mexico
7.4.2 Nov 30, 2016: EndoStim Opens its New Corporate Headquarters in Dallas
7.4.3 Aug 17, 2016: ResMed Takes Fisher & Paykel to Court over Patents
7.4.4 Jun 30, 2016: NuVasive Agrees to Settle Patent Litigation With Medtronic
7.4.5 Jun 30, 2016: Wake Forest Baptist Receives Specialty Pharmacy Accreditation
7.4.6 Jun 27, 2016: Greatbatch Renamed Integer Holdings
7.5 Other Significant Developments
7.5.1 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors
7.5.2 Dec 29, 2016: Zynex General Update and November Orders
7.5.3 Sep 20, 2016: NEO Tech Offers Microelectronics Miniaturization for Medical Implantable Device OEMs
7.5.4 Sep 13, 2016: Zynex Announces August Orders
7.5.5 Aug 30, 2016: SANUWAVE Health Reports Record Year to Date Order Book for orthoPACE and dermaPACE – Up 280% Over 2015
7.5.6 Aug 16, 2016: Zynex Announces July Orders
7.5.7 Jul 27, 2016: Intrinsic Imaging Awarded International Clinical Trial to Determine Efficacy of Innovative Class III Medical Device
7.5.8 Jul 22, 2016: Zynex Announces June Orders
7.5.9 Jun 08, 2016: Boston Scientific Announces Restructuring Program to Support Long-Term Growth and Innovation
7.5.10 Jun 02, 2016: Zynex Reports Electrotherapy Orders for May
7.5.11 May 25, 2016: Sanofi Files Consent Solicitation To Remove and Replace Medivation’s Board
7.6 Product News
7.6.1 Feb 24, 2017: SANUWAVE Receives U.S. Patent for a Special Construction of Shock Wave Electrodes and the Method to Adjust Their Spark Gap
7.6.2 Feb 15, 2017: Bioness Expands its Technology Leadership Position in Rehabilitation by Introducing Groundbreaking Products at the 2017 American Physical Therapy Association's Combined Sections Meeting
7.6.3 Jan 24, 2017: SANUWAVE Issued U.S. Patent for a Shock Wave Applicator Construction With Movable Electrode
7.6.4 Jan 19, 2017: Brain stimulation used like a scalpel to improve memory
7.6.5 Oct 19, 2016: Bioness to Exhibit at American Academy of Physical Medicine and Rehabilitation Annual Assembly
7.6.6 Aug 29, 2016: Stimwave’s Drug-Free Wireless Pain Relief Neurostimulator Changing the Lives of People Suffering From Chronic Pain
7.7 Strategy And Business Planning
7.7.1 Aug 09, 2016: EDA Board Acts to Encourage Global Pharmaceutical Company Allergan to Expand in New Jersey
7.7.2 Jul 05, 2016: Sanofi Enters Into Confidentiality Agreement With Medivation And Will Be Provided Due Diligence Access And Confidential Information
7.7.3 May 20, 2016: Avalon Ventures and COI Pharmaceuticals Announce First Milestones for Sitari Pharmaceuticals and Silarus Therapeutics and Formation of Eighth Company
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Company Share Analysis
8.1.5 Distribution Share Analysis
8.1.6 Benchmarking
8.2 GlobalData Consulting
8.3 Contact Us
8.4 Disclaimer
1.1 List of Tables
Table 1: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Table 2: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Table 3: Neurostimulation Devices Market, United States, Volume (Units), Historic, 2009-2016
Table 4: Neurostimulation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Table 5: Neurostimulation Devices Market, United States, Average Price ($), Historic, 2009-2016
Table 6: Neurostimulation Devices Market, United States, Average Price ($), Forecast, 2016-2023
Table 7: Neurostimulation Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2015-2016
Table 8: Neurostimulation Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016
Table 9: Neurostimulation Devices Market Pipeline Products
Table 10: Nevro Completes Public Offering of 1.75% Notes Due 2021 for USD172.5 Million
Table 11: Helius Medical Technologies Raises USD9.5 Million in Public Offering of Shares
Table 12: Zynex to Raise USD1.5 Million in Private Placement
Table 13: Helius Medical Raises USD1.4 Million in Private Placement of Shares upon Exercise of Warrants
Table 14: NeuroMetrix Raises USD21.3 Million in Private Placement of Shares and Warrants
Table 15: Dynatronics Raises USD7.8 Million in Venture Financing
Table 16: SetPoint Medical Raises Funds through Venture Financing
Table 17: ReliefBand Technologies to Raise USD8 Million in Venture Financing
Table 18: Checkpoint Surgical Raises USD0.5 Million in Venture Financing
Table 19: ElectroCore Raises USD1.5 Million in Venture Financing
Table 20: Autonomic Technologies Raises Additional USD23 Million in Venture Financing
1.2 List of Figures
Figure 1: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016
Figure 2: Neurostimulation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023
Figure 3: Neurostimulation Devices Market, United States, Volume (Units), Historic, 2009-2016
Figure 4: Neurostimulation Devices Market, United States, Volume (Units), Forecast, 2016-2023
Figure 5: Neurostimulation Devices Market, United States, Company Share (%) 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report